These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 20420580)
1. Calpain-mediated down-regulation of myelin-associated glycoprotein in lysophosphatidic acid-induced neuropathic pain. Xie W; Uchida H; Nagai J; Ueda M; Chun J; Ueda H J Neurochem; 2010 May; 113(4):1002-11. PubMed ID: 20420580 [TBL] [Abstract][Full Text] [Related]
2. Autotaxin and lysophosphatidic acid1 receptor-mediated demyelination of dorsal root fibers by sciatic nerve injury and intrathecal lysophosphatidylcholine. Nagai J; Uchida H; Matsushita Y; Yano R; Ueda M; Niwa M; Aoki J; Chun J; Ueda H Mol Pain; 2010 Nov; 6():78. PubMed ID: 21062487 [TBL] [Abstract][Full Text] [Related]
3. Lysophosphatidic acid as the initiator of neuropathic pain. Ueda H Biol Pharm Bull; 2011; 34(8):1154-8. PubMed ID: 21804198 [TBL] [Abstract][Full Text] [Related]
4. LPA-mediated demyelination in ex vivo culture of dorsal root. Fujita R; Kiguchi N; Ueda H Neurochem Int; 2007 Jan; 50(2):351-5. PubMed ID: 17056157 [TBL] [Abstract][Full Text] [Related]
5. Lysophosphatidic acid-3 receptor-mediated feed-forward production of lysophosphatidic acid: an initiator of nerve injury-induced neuropathic pain. Ma L; Uchida H; Nagai J; Inoue M; Chun J; Aoki J; Ueda H Mol Pain; 2009 Nov; 5():64. PubMed ID: 19912636 [TBL] [Abstract][Full Text] [Related]
6. Profiling of BoNT/C3-reversible gene expression induced by lysophosphatidic acid: ephrinB1 gene up-regulation underlying neuropathic hyperalgesia and allodynia. Uchida H; Matsumoto M; Ueda H Neurochem Int; 2009; 54(3-4):215-21. PubMed ID: 19111589 [TBL] [Abstract][Full Text] [Related]
7. Evidence for de novo synthesis of lysophosphatidic acid in the spinal cord through phospholipase A2 and autotaxin in nerve injury-induced neuropathic pain. Ma L; Uchida H; Nagai J; Inoue M; Aoki J; Ueda H J Pharmacol Exp Ther; 2010 May; 333(2):540-6. PubMed ID: 20123931 [TBL] [Abstract][Full Text] [Related]
8. Microglial activation mediates de novo lysophosphatidic acid production in a model of neuropathic pain. Ma L; Nagai J; Ueda H J Neurochem; 2010 Nov; 115(3):643-53. PubMed ID: 20722972 [TBL] [Abstract][Full Text] [Related]
9. Activation of Lysophosphatidic Acid Receptor Type 1 Contributes to Pathophysiology of Spinal Cord Injury. Santos-Nogueira E; López-Serrano C; Hernández J; Lago N; Astudillo AM; Balsinde J; Estivill-Torrús G; de Fonseca FR; Chun J; López-Vales R J Neurosci; 2015 Jul; 35(28):10224-35. PubMed ID: 26180199 [TBL] [Abstract][Full Text] [Related]
10. Involvement of lysophosphatidic acid-induced astrocyte activation underlying the maintenance of partial sciatic nerve injury-induced neuropathic pain. Ueda H; Neyama H; Nagai J; Matsushita Y; Tsukahara T; Tsukahara R Pain; 2018 Nov; 159(11):2170-2178. PubMed ID: 29939962 [TBL] [Abstract][Full Text] [Related]
12. Identification of the sensory nerve fiber responsible for lysophosphatidic acid-induced allodynia in mice. Ohsawa M; Miyabe Y; Katsu H; Yamamoto S; Ono H Neuroscience; 2013 Sep; 247():65-74. PubMed ID: 23685168 [TBL] [Abstract][Full Text] [Related]
13. Lysophosphatidylcholine induces neuropathic pain through an action of autotaxin to generate lysophosphatidic acid. Inoue M; Xie W; Matsushita Y; Chun J; Aoki J; Ueda H Neuroscience; 2008 Mar; 152(2):296-8. PubMed ID: 18280050 [TBL] [Abstract][Full Text] [Related]
14. Autotaxin, a synthetic enzyme of lysophosphatidic acid (LPA), mediates the induction of nerve-injured neuropathic pain. Inoue M; Ma L; Aoki J; Chun J; Ueda H Mol Pain; 2008 Feb; 4():6. PubMed ID: 18261210 [TBL] [Abstract][Full Text] [Related]
15. Upregulation and redistribution of ephrinB and EphB receptor in dorsal root ganglion and spinal dorsal horn neurons after peripheral nerve injury and dorsal rhizotomy. Song XJ; Cao JL; Li HC; Zheng JH; Song XS; Xiong LZ Eur J Pain; 2008 Nov; 12(8):1031-9. PubMed ID: 18321739 [TBL] [Abstract][Full Text] [Related]
16. Initiation of neuropathic pain requires lysophosphatidic acid receptor signaling. Inoue M; Rashid MH; Fujita R; Contos JJ; Chun J; Ueda H Nat Med; 2004 Jul; 10(7):712-8. PubMed ID: 15195086 [TBL] [Abstract][Full Text] [Related]
17. Peripheral mechanisms of neuropathic pain - involvement of lysophosphatidic acid receptor-mediated demyelination. Ueda H Mol Pain; 2008 Apr; 4():11. PubMed ID: 18377664 [TBL] [Abstract][Full Text] [Related]
18. Molecular mechanisms of neuropathic pain-phenotypic switch and initiation mechanisms. Ueda H Pharmacol Ther; 2006 Jan; 109(1-2):57-77. PubMed ID: 16023729 [TBL] [Abstract][Full Text] [Related]
19. Lysophosphatidic acid and its receptors LPA1 and LPA3 mediate paclitaxel-induced neuropathic pain in mice. Uchida H; Nagai J; Ueda H Mol Pain; 2014 Nov; 10():71. PubMed ID: 25411045 [TBL] [Abstract][Full Text] [Related]
20. Activation and expression of μ-calpain in dorsal root contributes to RTX-induced mechanical allodynia. Yuan XC; Wu CH; Gao F; Li HP; Xiang HC; Zhu H; Pan XL; Lin LX; Liu YS; Yu W; Tian B; Meng XF; Li M Mol Pain; 2017; 13():1744806917719169. PubMed ID: 28714350 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]